Reed Jobs Focuses on Cancer Research Over Family Legacy

During a recent chat at TechCrunch Disrupt, Reed Jobs, son of the late Steve Jobs, shared insights about his evolving role in the biotech sector. Three years ago, when we last caught up with him, his company Yosemite was just getting started, and the biotech industry was still recovering from a pandemic-induced slump.

Fast forward to now, and Yosemite has grown to a team of 17 talented individuals. The landscape is changing as several major drugs are nearing the end of their patent protections, opening doors for new developments and opportunities. Reed noted that artificial intelligence has transformed from a mere point of interest to a significant component of Yosemite’s operations.

“I didn’t anticipate Yosemite would progress this rapidly,” Reed admitted, reflecting the brisk pace at which innovation is happening. His shift in focus towards addressing serious health issues like cancer showcases a commitment to making a real difference, rather than merely riding on his family’s famous name.